ArticleMolecular therapy. Methods & clinical development2021

Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector.

Brenda J Seymour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.